Shlomit Ein Gal, Samuel Mathis, Bhavana Pathak, Moshe Frenkel
{"title":"The Role of Integrative Oncology in Patients Affected by Triple Negative Breast Cancer.","authors":"Shlomit Ein Gal, Samuel Mathis, Bhavana Pathak, Moshe Frenkel","doi":"10.1007/s11912-025-01711-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>This review examines the unmet needs of patients with triple-negative breast cancer (TNBC), the limitations of current treatment approaches, and the role of integrative modalities in symptom management, patient care, and quality-of-life enhancement. Despite advances in oncology, TNBC remains a clinical challenge due to its aggressive nature, intensive treatments, and disparities in access to care, leading to variable outcomes. This review summarizes recent progress in integrative oncology and its potential benefits for TNBC patients.</p><p><strong>Recent findings: </strong>TNBC patients face significant physical and psychosocial challenges, compounded by disparities in treatment and supportive care access. Continuous chemotherapy-based regimens often lead to accumulating symptoms, highlighting the need for integrative approaches. Evidence suggests that modalities such as nutritional counseling, physical activity programs, mind-body interventions (e.g., mindfulness, yoga) acupuncture and certain herbal remedies can help alleviate symptoms, improve well-being, and enhance resilience. A growing body of evidence supports the integration of these approaches into TNBC care to improve quality of life. The Society for Integrative Oncology has issued clinical practice guidelines recommending these modalities, yet challenges remain in optimizing personalized approaches and ensuring equitable access. Future research should focus on refining integrative strategies and increasing awareness of their benefits for TNBC patients.</p>","PeriodicalId":10861,"journal":{"name":"Current Oncology Reports","volume":" ","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Oncology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11912-025-01711-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of review: This review examines the unmet needs of patients with triple-negative breast cancer (TNBC), the limitations of current treatment approaches, and the role of integrative modalities in symptom management, patient care, and quality-of-life enhancement. Despite advances in oncology, TNBC remains a clinical challenge due to its aggressive nature, intensive treatments, and disparities in access to care, leading to variable outcomes. This review summarizes recent progress in integrative oncology and its potential benefits for TNBC patients.
Recent findings: TNBC patients face significant physical and psychosocial challenges, compounded by disparities in treatment and supportive care access. Continuous chemotherapy-based regimens often lead to accumulating symptoms, highlighting the need for integrative approaches. Evidence suggests that modalities such as nutritional counseling, physical activity programs, mind-body interventions (e.g., mindfulness, yoga) acupuncture and certain herbal remedies can help alleviate symptoms, improve well-being, and enhance resilience. A growing body of evidence supports the integration of these approaches into TNBC care to improve quality of life. The Society for Integrative Oncology has issued clinical practice guidelines recommending these modalities, yet challenges remain in optimizing personalized approaches and ensuring equitable access. Future research should focus on refining integrative strategies and increasing awareness of their benefits for TNBC patients.
期刊介绍:
This journal aims to review the most important, recently published clinical findings in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer.
We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.